PEAK6 Investments’s Cytosorbents Corp CTSO Stock Holding History

PEAK6 Investments’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-33,800	Closed	-$170K	–	3502
2019 Q3	$170K	Buy	+33,800	New	+$197K	﹤0.01%	2988

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

PEAK6 Investments's CTSO Position: Q4 2019 in Review

PEAK6 Investments sold out of Cytosorbents Corp (CTSO) in Q4 2019, closing a stake of 5,243 shares — an estimated $26K sold.

PEAK6 Investments first reported a position in CTSO in Q3 2018 and held it in 2 quarters. The position peaked at $329K in Q3 2018. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

PEAK6 Investments reported no remaining Cytosorbents Corp position as of Q4 2019 after selling out during the quarter.
PEAK6 Investments sold 5,243 Cytosorbents Corp shares in Q4 2019, an estimated $26K.
PEAK6 Investments first reported a position in Cytosorbents Corp in Q3 2018 and held it in 2 quarters.
PEAK6 Investments's Cytosorbents Corp position peaked at $329K in Q3 2018.
72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on PEAK6 Investments's 13F filing for Q4 2019, filed 13 Feb 2020.